At a glance
- Originator Kyowa Hakko
- Class Irritable bowel syndrome therapies; Small molecules
- Mechanism of Action Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Dyspepsia; Inflammatory bowel diseases
Most Recent Events
- 14 Feb 2006 No development reported - Preclinical for Dyspepsia in Japan (unspecified route)
- 14 Feb 2006 No development reported - Preclinical for Inflammatory bowel disease in Japan (unspecified route)
- 13 May 2002 A preclinical study has been added to the Digestive System Disorders pharmacodynamics section